Использование цераксона в лечении когнитивных расстройств у пациентов с дисциркуляторной энцефалопатией

Supervising 50 patients with a diagnosis of discirculatory encephalopathy stage I (from age of 45 to 70 years), was held at clinical-neurological examination, psychodiagnostic testing, as well as following systems examination with the use of induced cognitive potentials P300. All patients in line with the standard treatment were treated with the drug «Ceraxon» with dose of 2000 mg for 10 days. The results of the study indicates an improvement in indicators of psychodiagnostic testing revealing the neurophysiological the positive dynamics of the background in the treatment.